Product Name	MF	CAS	Details

Argireline

C34H60N14O12S

616204-22-9

Details

Rosuvastatin methyl ester

C23H30FN3O6S

147118-40-9

Details

4-Chloromethyl-5- meth-yl-1,3-dioxol- 2-one

C5H5ClO3

80841-78-7

Details

Ethyl 4-(1-hydroxy-1-methyl-ethyl)-2-propyl- imidazole-5- carboxylate

C12H20N2O3

144689-93-0

Details

Methyl 4'-bromomethyl biphenyl-2-carboxylate

C15H13BrO2

114772-38-2

Details

2-n-Propyl-4-methyl-6-(1-methylbenzimi- dazole-2-yl)benz- imidazole

C19H20N4

152628-02-9

Details

Valsartan methyl ester

C25H31N5O3

137863-17-3

Details

Silodocin P-1 oxalate

Details

Rabamipide Na

Details

Dapoxetine free base

C21H23NO

119356-77-3

Details

Tadanafil P-1

C22H19ClN2O5

171489-59-1

Details

Dantrolene free base

C14H10N4O5

85008-71-5

Details

Varenicline free base

C13H13N3

249296-44-4

Details

N-(4-cyanophenyl)- glycine

C9H8N2O2

42288-26-6

Details

Ethyl N-[3-amino-4-(methylamino)benzoyl]-N- pyridin-2-yl-beta- alaninate

C18H22N4O3

212322-56-0

Details

Ethyl N-[(2-{[(4-cyanophenyl)amino]methyl}-1- methyl-1H-benz- imidazol-5-yl)- carbonyl]-N-pyridin- 2-yl-beta-alaninate

C27H26N6O3

211915-84-3

Details

(S)-2,3-Dimethyl-3-(( triethylsilyl)oxy)butan-1-ol

C12H28O2Si

957997-83-0

Details

(S)-3-(methoxymetho-xy)-2,3-dimethylbutan-1-ol

C8H18O3

1217719-34-0

Details

(R)-(2,3-dimethyl-3-(( triethylsilyl) oxy)butyl)- diphenylphosphine oxide

C24H37O2PSi

1227926-70-6

Details

(R)-(2,3-dimethyl-3- butyl)diphenyl phosphineoxide

C18H23OP

Details

(2S)-2-((1R,3aR,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol

C19H38O2Si

215509-33-4

Details

(1R,3aR,7aR)-1-((2R,5S,E)-6-(methoxy methoxy)-5,6-dimethylhept-3-en-2-yl)-7a- methylhexahydro- 1H-inden-4(2H)-one

C21H36O3

100858-26-2

Details

(1R,3aR,7aR)-1-((2R,5S,E)-5,6-dimethyl-6- ((triethylsilyl)oxy)hept-3-en-2-yl)-7a-methyl hexahydro-1H- inden-4(2H)-one

C25H46O2Si

950586-26-2

Details

2-((3R,5R)-3,5-bis(( tert-butyldimethyl silyl)-oxy) cyclohexylidene) ethanol

C20H42O3Si2

139356-37-9

Details

(2-((3R,5R)-3,5-bis(( tert-butyldimethyl- silyl)oxy)cyclohexyl- idene)ethyl)diphenylphosphine oxide

C32H51O3PSi2

139356-39-1

Details

ATB-1

C10H13FO

1262414-96-9

Details

ATB-4

C8H5BrClF3

237761-77-2

Details

Diallyl bisphenol A

C21H24O2

1745-89-7

Details

5,6-Dihydroxyindole

C8H7NO2

3131-52-0

Details

5,6-Dihydroxy-1H-Indole-2-Carboxylic Acid

C9H7NO4

4790-08-3

Details

Methyl 5,6-dihydroxy-1H-indole-2-Carboxylate

C10H9NO4

10131-14-3

Details

2,2-dimethyl-5H-1,3-dioxol[4,5-f]indole

C11H11NO2

437757-21-6

Details

(E)-methyl 3-(2,2-dimethylbenzo[d][1,3]dioxol-5-yl)acrylate

C13H14O4

2187481-85-0

Details

Cis-Sertraline-D-Madenlic acid

Details

Sitagliptin impurity 1~5

C10H11ClF3NO2

Details

Methyl caffeate

C10H10O4

67667-67-8

Details

Quinic acid

C7H12O6

77-95-2

Details

Phenethyl caffeate

C17H16O4

104594-70-9

Details

ATB-9

C12H9F6NO2

875444-10-3

Details

Caffeic acid

C9H8O4

331-39-5

Details

Crisaborole impurity 2

C14H12BNO4

1187188-59-5

Details

Crisaborole impurity 3

C14H11NO2

888967-63-3

Details

Sitagliptin impurity 1

C16H19F5N5O5P

1345822-87-8

Details

Sitagliptin impurity 2

C16H19F5N5O5P

1345822-86-7

Details

Sitagliptin impurity 3

C16H16F6N5O5P

823817-58-9

Details

Lesinurad sodium

C17H13BrN3O2S.Na

1151516-14-1

Details

de-bromo Lesinurad

C17H15N3O2S

1533519-93-5

Details

Benserazide HCl

C10H16ClN3O5

14919-77-8

Details

Benserazide P-1

C10H14ClN3O5

1353749-74-2

Details

Silodosin P-1 oxalate

C27H32F3N3O7

1883697-83-3

Details

Roxatidine impurity 1

C12H17NO

73279-04-6

Details

Roxatidine impurity 3

C16H24N2O2

78274-00-7

Details

Roxatidine impurity 4

C17H27ClN2O2

97900-87-3

Details

Erdosteine

C8H11NO4S2

84611-23-4

Details

Ilaprazole

C19H18N4O2S

172152-36-2

Details

Ilaprazole intermediate P-3

C11H9N3S

172152-53-3

Details

Ilaprazole impurity 1

C19H18N4O3S

172152-37-3

Details

Ilaprazole impurity 3

C9H9N3OS

84445-90-9

Details

Ilaprazole impurity 4

C11H9N3O

1018229-53-2

Details

Fexuprazan P-4

C13H11F2NO3

1902955-29-6

Details

Fexuprazan P-1

C18H12F3NO4S

1902955-31-0

Details

N-Bn Tegoprazan parent nucleus

C18H19N3O2

1640981-20-9

Details

N-Ts Tegoprazan P-1

4942485-42-9

Details

N-Bn Tegoprazan P-1

Details

R-Tegoprazan isomer

C20H19F2N3O3

942195-56-4

Details

Vonoprazan Fumarate

C21H20FN3O6S

1260141-27-2

Details

Deoxycholic acid P-1

C28H46O5

181270-68-8

Details

Deoxycholic acid impurity 1

Details

Deoxycholic acid impurity 2

C26H44O4

Details

Deoxycholic acid impurity 3

Details

Sodium Picosulfate impurity A

C18H16NNaO5S

32500-19-9

Details

Diclofenac Epolamine impurity 2

C13H9Cl2NO2

13625-57-5

Details

Diclofenac Epolamine impurity 4

C14H11BrClNO2

127792-23-8

Details

Diclofenac Epolamine impurity 6

C8H8N2

42088-52-8

Details

Diclofenac Epolamine impurity 7

C13H11Cl2N

172494-87-0

Details

Pranoprofen P-2

C15H12ClNO2

146330-68-9

Details

Pranoprofen impurity B

C15H11NO3

52549-22-1

Details

Raloxifene HCl P-1

C30H32ClNO4S

84541-36-6

Details

Raloxifene impurity 1

C29H29NO4S.ClH

84541-37-7

Details

Raloxifene impurity 2

C29H29NO4S.ClH

173773-26-7

Details

Glimepiride Cis isomer

C24H34N4O5S

684286-46-2

Details

Glimepiride methyl ester

C18H23N3O6S

119018-30-3

Details

Oseltamivir degradation impurity 1

Details

Oseltamivir degradation impurity 2

Details

Grape Leaf Extract

C32H30O11

Details

Pancreatin

N/A

8049-47-6

Details

Liver Extract Anti-toxic Fraction

Details

Omeprazole Enteric pellet

Details

Lansoprazole Enteric pellet

Details

Duloxetin HCl Enteric pellet

Details

Roxatidine Acetate HCl Sustained-release pellet

Details

Tamsulosin HCl Sustained-release pellet

Details

1-(2-fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea

Details

SPH4336

C27H30F2N8.C4H4O4

2765997-88-2

Details

(4-isobutoxyphenyl)methanol

C11H16O2

500547-59-1

Details

Plazomicin impurity PLZA000017

Details

QBH-196-G;N-[3-fluoro-4-[[6-methoxy-7-[3-(4-methyl-1-piperidinyl)propoxy]-4-quinolinyl]oxy]phenyl]- Hydrazinecarboxamide

C26H32FN5O4

1449763-35-2

Details

HPK1-IN-7

C24H22N6O4

2320462-65-3

Details

Asundexian intermediate

C11H12BrFN2O2

2376389-34-1

Details

(E)-6,6'-(triaz-1-ene-1,3-diylbis(4,1-phenylene))bis(5-methyl-4,5-dihydropyridazin-3(2H)-one)

1643436-59-1

Details

Plogosertib (CYC140)

C34H48N8O3

1137212-79-3

Details

BI-6727 intermediate

C22H34N4O2

882660-39-1

Details

1H-Indole-3-carboxylic acid, 6-bromo-5-hydroxy-4-(1H-imidazol-1-ylmethyl)-1-methyl-2-[(phenylsulfinyl)methyl]-, ethyl ester;

C23H22BrN3O4S

865171-50-2

Details

2-(benzyl(tert-butyl)amino)-1-(4-(2-(4-hydroxy-3-(hydroxymethyl)phenyl)-2-oxoethoxy)-3-(hydroxymethyl)phenyl)ethan-1-one

Details

Plazomicin impurity PLZA000029

Details

Orbifloxacin

C19H20F3N3O3

113617-63-3

Details

Pimavanserin Tartrate

C29H40FN3O8

706782-28-7

Details

Plazomicin

C25H48N6O10

1154757-24-0

Details

((1R,2R)-2-(3-(tert-butoxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium )

C28H40NO6+

1075726-99-6

Details

Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-, iodide (1:1), (1R)-

C22H30NO4+

732929-47-4

Details

1-(4-(3-Chloropropoxy)-5-methoxy-2-nitrophenyl)ethanone

C12H14ClNO5

1160707-44-7

Details

3-iodo-6-methyl-1H-pyrazolo[3,4-b]pyridine

C7H6IN3

1352396-72-5

Details

MRX-I

C18H15F3N4O4

1112968-42-9

Details

N,N'-((1S,2S)-cyclohexane-1,2-diyl)bis(N-methylpicolinamide)

C20H24N4O2

474937-35-4

Details

Asundexian intermediate

C15H10ClF3N4O2

2376389-33-0

Details

SPH3127 impurity G

Details

4-Isobutoxybenzyl (4-isobutoxybenzyl)carbamate

Details

5-(2-(benzyl(tert-butyl)amino)acetyl)-2-hydroxybenzyl acetate

Details

Pradofloxacin

C21H21FN4O3

195532-12-8

Details

Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2S,2′S)-, )

C53H72N2O12+2

96946-45-1

Details

Isoquinolinium, 1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2,2-dimethyl-, iodide (1:1), (1R)-

C22H30NO4.I

41431-32-7

Details

Isoquinolinium, 2,2′-[1,5-pentanediylbis[oxy(3-oxo-3,1-propanediyl)]]bis[1-[(3,4-dimethoxyphenyl)methyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-2-methyl-, (1R,1′R,2R,2′S)-, benzenesulfonate (1:2)

C59H77N2O15S+

96946-44-0

Details

2-chloro-6-methylnicotinonitrile

C7H5ClN2

28900-10-9

Details

Plazomicin sulfate

C25H50N6O14S

1380078-95-4

Details

tert-butyl (R)-3-(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)propanoate free base

C27H37NO6

1075726-70-3

Details

Plazomicin impurity PLZA000002

C27H42N6O11

1154758-54-9

Details

Plazomicin intermediate PLZA000006

C43H76N6O17

1154758-63-0

Details

1,1-bis(4-fluorobenzyl)-3-(4-isobutoxybenzyl)urea

C26H28F2N2O2

2518374-84-8

Details

Cycloheptatriene

C7H8

544-25-2

Details

bis(4-isobutoxybenzyl)amine hydrochloride

C22H31NO2.ClH

2514955-85-0

Details

SPH5030-SM3 (R,Z)-2-fluoro-3-(1-methylpyrrolidin-2-yl)acrylic acid hydrochloride

C8H12FNO2.ClH

2761913-41-9

Details

methyl 4-(trifluoromethyl)benzoate；

C9H7F3O2

2967-66-0

Details

sEH/AChE inhibitor

C31H35ClF3N5O3

2490589-10-9

Details

SPH3127 impurity I

Details

Deuterium I031-D

Details

6-methyl-1H-pyrazolo[3,4-b]pyridin-3-amine

C7H8N4

79173-38-9

Details

ANC

C13H19N3O2

1149333-40-3

Details

CS-2064

C30H30F3N5O

1333146-24-9

Details

ethyl 4-(trifluoromethyl)； Benzoate

C10H9F3O2

76783-59-0

Details

PCB

C15H11ClF2N4

1231930-43-0

Details